期刊文献+

孕期不同阶段铅暴露时大鼠胎盘基质金属蛋白酶-9及组织抑制剂-1的表达 被引量:1

Effects of lead exposure during different gestation period to rat placenta and the expression of matrix metalloproteinase-9 and tissue inhibitor of metaUoproteinase-1
原文传递
导出
摘要 目的观察不同阶段铅暴露对孕鼠胎盘基质金属蛋白酶.9(MMP-9)及其组织抑制剂-1(TIMP-1)表达的影响,探讨铅的胎盘毒性机制。方法108只大鼠随机分为4组,每组27只(雌雄比为2:1)合笼饲养,于孕期不同阶段饮服0.025%醋酸铅。对照组孕期全程(1-20d)饮服蒸馏水;实验A组孕早期(1~10d)饮服醋酸铅,孕后期(11—20d)饮服蒸馏水;实验B组孕早期(1—10d)饮服蒸馏水,孕后期(11—20d)饮服醋酸铅;实验C组孕期全程(1.20d)饮服醋酸铅。孕末期腹腔静脉取血,原子吸收光谱法测定血铅,免疫组化法测定胎盘滋养层细胞MMP-9和TIMP-1的表达。结果(1)对照组孕鼠孕末期平均血铅水平为(0.04±0.01)μMol/L,实验组孕鼠孕末期平均血铅水平均高于0.483μMol/L,实验C组血铅水平最高;(2)MMP-9和TIMP-1在胎盘组织中的表达部位主要位于滋养层细胞胞质;(3)胎盘滋养层细胞MMP-9表达4组间总体比较差异有统计学意义(X^2=28.381,P〈0.01),血铅水平最高的实验C组阳性表达率最低,与对照组比较差异有统计学意义(P〈0.05);(4)胎盘滋养层细胞TIMP-1表达4组间总体比较差异有统计学意义(X^2=18.177,P〈0.05),表达强度以实验C组最高,实验A组次之,与对照组比较差异有统计学意义(P〈0.05)。结论孕期MMP-9和TIMP-1的表达部位主要位于胎盘滋养层细胞。铅中毒程度越重,MMP-9和TIMP-1的表达强度改变越明显。MMP-9和TIMP-1的表达失衡可能是铅致胎盘损伤的病理机制之一。 Objective To explore the pathogenesis of placenta toxicity of lead exposure during different gestation periods by testing the blood lead level and the expression of matrix metalloproteinase-9(MMP-9) and tissue inhihitorof metalloproteinase-l(TIMP-1) in rat placenta. Melhods 108 Wistar rats(72 female, 36 male) were randomly divided into four groups. All rats were orally fed with 0.025 % lead acetate during different gestation periods. Blood was obtained from the abdominal vena eava and the lead level in maternal blood was measured by means of atomic absorption spectrometry at the end of the pregnancy. The expression of MMP-9 and TIMP-1 in rat placenta was tested by means of immunohistochemistry. Results ( 1 )The blood lead level in the end of pregnancy was 0.04μmol/L ± 0.01 in control group, while in experimental groups the blood lead levels were all higher than 0.483μmol/L, among them the highest blood lead level was in experimental group C. (2) The expression of MMP-9 and TIMP-1 mostly distributed in trophoblastic cells. (3)The expression of MMP-9 had significant difference in four groups( X^2 = 28.381, P 〈 0.01) .The expression of MMP-9 was significantly reduced in experimental group C (the highest blood lead level) compared with control group. (4) The expression of TIMP-1 had significant difference in four groups ( X^2 = 18.177, P 〈 0.05 ). The expression of TIMP- 1 was significantly increased in experimental group A, C compared with control group. Conclusions The expression of MMP-9 and TIMP-1 in rat placenta mostly distributed in trophoblasfic cells. They would change when the degree of lead poisoning was more serious. The imbalance of expression of MMP-9/TIMP- 1 may play an important role in pathogenesis of placenta toxicity of lead exposure.
出处 《国际儿科学杂志》 2008年第3期199-201,F0003,共4页 International Journal of Pediatrics
基金 青岛市科技发展计划基金资助项目(06-2-2-3nsh)
关键词 模型 动物 胎盘 基质金属蛋白酶9 金属蛋白酶类组织抑制剂 Lead Models Animal Placenta Matrix Metalloproteinase-9 Tissue Inhibitor of Metalloproteinases
  • 相关文献

参考文献12

  • 1Manton WI, Angle CR, Stanrek KL, et al. Release of lead from bone in pregnancy and lactation. Envion Res, 2003,92 ( 2 ) : 139-151.
  • 2Cohen M, Meisser A, Bisehof P. Metalloproteinases and human placental invasiveness.Placenta,2006,27(8):783-793
  • 3Aversa F,Terenzi A,Tabilio A,et al.Full haplotype mismatched hematopoietic stem-cell transplantation:A phase Ⅱ study in patients with acute leukemia at high risk of relapse. J Clin Oncol, 2005,23( 15): 3447-3454.
  • 4Handgretinger R,Schumm M,Ling P. et al. Transplantation of megadoses of purified haploidentical stem cells.Ann N Y Acad Sci. 1999.827:351-361.
  • 5van Rood JJ,Loberiza FR,Jr,Zhang MJ ,et al .Effect of tolerance to noninherited maternal antigens on the occurrence of GVHD after bone marrow transplantation from a parent or an HLA haploidentical sibling. Blood. 2002,99(5) :1572-1577.
  • 6Ruggeri L, Mancusi A, Burchielli E, et al. Natural killer cell alloreactivity in allogeneic hematopoetic transplantation. Curr Opin Oncol, 2007,19 (2) : 142-147.
  • 7Kalwak K,Moson I,Cwian J,et al .A prospective analysis of immune recovery in children following allogeneic transplantation of t-cell-depleted or non-T- cell-depleted hematopoietic cells from HLA-disparate family donors. Transplantat Proc.2003 ,35(4) : 1551-1555.
  • 8Lu DP, Dong L,Wu T, et al. Conditioning including antithymocyte globuling followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcome to HLA-identical sibling transplantation. Blood, 2006,107 ( 8 ) : 3065-3073.
  • 9梁辉,王昀,郭若冰,程志英,薛惠良,顾龙君.外周血CD34^+造血干细胞加适量T细胞输注进行HLA半相合的异体移植[J].临床儿科杂志,2002,20(1):28-30. 被引量:4
  • 10Ji SQ,Chen HR, Yan HM,et al. Anti-CD25 monoclonal antibody(basilixinab) for prevention of GVHD after haploidentical bone mamow transplantation for hematological malignancies. Bone Marrow Transplant ,2005,36(4) :349-354.

二级参考文献19

  • 1Slavin S,Ackerstein A,Naparstek E,et al.The graft-versus-leukemia (GVL) phenomenon:is GVL separable from GVHD? Bone Marrow Transplantation,1990,6:155-161.
  • 2Amlot PL,Rawlings E,Fernando ON,et al.Prolonged action of a chimeric interleukin-2 receptor(CD25) monoclonal antibody used in cadaveric renal transplantation.Transplantation,1995,60:748-755.
  • 3Baker MB,Altman NH,Podack ER,et al.The role of cell-mediated cytotoxicity in acute GVHD after MHC-mediated bone marrow transplantation in mice.J Exp Med,1996,183:2645-2656.
  • 4Harris DT,Sakiestewa D,Lyons C,et al.Prevention of graft-versus-host disease (GVHD) by elimination of recipient-reactive donor T cells with recombinant toxins that target the interleukin2 (IL-2) receptor.Bone Marrow Transplantation,1999,23:137-144.
  • 5Montagna D,Yvon E,Calcaterra V,et al.Depletion of alloreactive T cells by a specific anti-interleukin-2 receptor P55 chain immuotoxin dose not impair in vitro antileukemia and antiviral activity.Blood,1999,93:550-556.
  • 6Fleming DR,Henslee-Downey PJ,Romond EH,et al.Allogeneic bone marrow transplantation with T-cell depleted partially matched related donors for advanced acute lymphblastic leukemia in children and adults:a comparative matched cohort study.Bone Marrow Transp
  • 7Goldman FD,Rumelhart SL,Dealacron P,et al.Poor outcome in children with refractory/relapsed leukemia undergoing bone marrow transplantation with mismatched family member donors.Bone Marrow Transplantation,2000,25:943-948.
  • 8Przepiorka D,Weisdorf D,Martin P,et al.Consensus conference on acute GVHD grading.Bone Marrow Transplantation,1995,15:825-828.
  • 9Vowels MR,Honeyman M,Ziegler J,et al.Searches for matched and closely matched related and unrelated marrow donors undertaken in paediatric unin.J Pediatr Child Health,1992,28:379-382.
  • 10Beatty PC,Clift RA,Mickelson EM,et al.Marrow transplantation from related donors other than HLA-identical siblings.N Engl J Med,1985,313:765-771.

共引文献9

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部